Authors
Latest:
Complex Multidisciplinary Care of an AYA With Ewing SarcomaThis case demonstrates the pivotal role of a cohesive multidisciplinary team in navigating the complex care of oncology patients from diagnosis, treatment, and posttreatment surveillance.
Latest:
Navigating CNS Disease in EGFR-Mutant NSCLCPanelists discuss how both amivantamab plus lazertinib and osimertinib-based regimens show good central nervous system (CNS) activity for patients with baseline brain metastases, with treatment choice influenced more by patient-specific factors such as bleeding risk and anticoagulation contraindications than by CNS efficacy differences.
Latest:
Case Study: Bridging the Gap for Patients With Metastatic CRCAdvanced practice providers have the opportunity to instill hope in patients through education and personalized care.
Latest:
More Than A “Side Effect”: Why Pediatric Hearing Loss Is So DetrimentalAn expert discusses the consequences of cisplatin-induced hearing loss and ongoing research efforts to eliminate this associated risk for children receiving the treatment.
Latest:
Supporting Patients Through New Breast Cancer TreatmentsThe presence of biomarkers, even in small amounts, can shape the course of treatment for a patient, says Andy Guinigundo, MSN, RN, CNP, ANP-BC.
Latest:
Navigating Difficult Conversations in Cancer Pain ManagementDifficult conversations in cancer pain management should include core values and principles, setting realistic expectations, and building the patient-client relationship from the very beginning.
Latest:
Symptom Management in CheckMate-73L TrialNagla Abdel Karim, MD, explains how researchers will address safety and manage potential adverse events in the ongoing phase 3 CheckMate-73L trial.
Latest:
Opinion: Nurses Need to Start Conversations About Genetic TestingLiz-Hunter Brack, RN, discusses how oncology nurses can play an important role in patient education surrounding genetic testing.
Latest:
Benefits, Risks With EBRT Plus SADT in Intermediate-Risk Prostate CancerIncrease in QOL and decrease in sexual function are among the benefits and risks, respectively, of adding SADT to EBRT for intermediate-risk prostate cancer.
Latest:
Zev Wainberg on Combination Chemotherapy Regimens in Metastatic Pancreatic CancerZev A. Wainberg, MD, discusses the implications of the findings from the phase 3 NAPOLI 3 trial for patients with metastatic pancreatic ductal adenocarcinoma.
Latest:
Expert Discusses Best Practices for Managing Breast Cancer–Related ToxicitiesCharles L. Loprinzi, MD, discusses the efficacy of agents like gabapentin and olanzapine to combat breast cancer treatment-related pains and speaks to the future of nonestrogenic toxicity management within this space.
Latest:
Empower Your Clinical Staff to Meet the Growing Patient VolumeOncology practices can create more access to care by leveraging the use of APPs, empowering nurses to practice at the top of their licensure, utilizing nurse navigators, and planning ahead.
Latest:
Elizabeth Cullen Discusses Avasopasem Manganese As A Potential Mucositis Management Strategy in Head and Neck CancersElizabeth R. Cullen, MSN, ARNP, provides an overview of avasopasem manganese and its potential role in reducing severe oral mucositis for patients undergoing radiotherapy.
Latest:
Medical Cannabis 101: What Oncology Nurses Need to KnowWith nearly two-thirds of the states allowing for medical cannabis use and the legalization of hemp, accessing cannabinoids has become much easier— especially for patients with cancer.
Latest:
AE Education Aids Breast Cancer Decisions, Says Survivorship ExpertPlanning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.
Latest:
Mary Katherine Montes de Oca on Cryocompression Therapy For Peripheral Neuropathy in Gynecologic CancersMary Katherine Montes de Oca, MD, discusses the potential benefit of cryocompression therapy in preventing peripheral neuropathy in patients with gynecologic cancers who are receiving chemotherapy.
Latest:
Advances in Head and Neck Cancers Yield New Clinical Implications for NursesAs the treatment paradigm continues to evolve, nurses play a key role in educating patients, monitoring treatments, and watching for adverse effects.
Latest:
Rx Road Map: Amivantamab (Rybrevant) Plus Lazertinib (Lazcluze)APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.
Latest:
Nurses May Advise Patients on Immunotherapy to Increase Fiber IntakeAn expert from The University of Texas MD Anderson Cancer Center offers advice on the best diet to enrich a patient’s microbiome and consequent immunotherapy response.
Latest:
Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment StrategiesExperts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.
Latest:
Cancer Care More Accessible Thanks to Launch of Telehealth and In-Home Infusion programsChevon Rariy, MD, outlines patient eligibility criteria, and the alterations to the nurse patient relationship, as CTCA launches the novel Oncology Clinic at Home Program.
Latest:
Sylvester’s Sexual Health After Cancer Program Expands to Meet Needs of Women with CancerKristin E. Rojas, M.D., FACS, FACOG, assistant professor of surgical oncology in the DeWitt Daughtry Department of Surgery and Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine, realized she had struck a chord with women being treated for cancer when she started the Menopause Urogenital Sexual Health and Intimacy Clinic (MUSIC).
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT CareTia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.
Latest:
Darolutamide Combination May Delay Disease Progression in Metastatic Hormone-Sensitive Prostate CancerAdding darolutamide to androgen deprivation therapy and docetaxel delayed the progression from metastatic hormone-sensitive prostate cancer to metastatic castration-resistant disease.
Latest:
Evaluation and Diagnosis of Multiple MyelomaPanelists discuss the multifaceted diagnostic process for multiple myeloma, emphasizing the integration of blood tests, genetic and imaging assessments, and patient education to guide personalized treatment planning and enhance patient engagement in care.
Latest:
Overcoming The Burden of Guilt as A NurseJanice Post-White, PhD, RN, FAAN, an oncology nurse and caregiver, discusses how she handled the guilt she felt following her son’s leukemia diagnosis.
Latest:
Mehra Details the Importance of PD-L1 Expression in HNSCC Treatment SelectionRanee Mehra, MD, discusses the link between PD-L1 expression and increased immunotherapy efficacy in head and neck squamous cell carcinoma, and what future treatment options may look like for patients in this space.
Latest:
Advanced Practice Providers Are Uniquely Suited for Survivorship CareAdvanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.
Latest:
Unmet Needs and Future Directions in the Management of CIMMartin Dietrich, MD, PhD, and Edgardo Santos, MD, FACP, offer closing remarks on unmet needs and future directions in the management of CIM including other disease states where trilaciclib may offer myeloprotective benefit.
